Retatrutide is administered as a once-weekly subcutaneous injection, consistent with other agents in this drug class
It remains an investigational medicinal product (IMP), meaning its use is restricted to formally approved clinical trials conducted under a Clinical Trial Authorisation (CTA) issued by the MHRA, in accordance with the UK Clinical Trials Regulations
Protein is the top lever for menopause weight loss and muscle, but how much do you actually need
Its a lovely spot to wind down the day with a drink in hand, toasting to the night ahead
However, I would be remiss if I didnt mention that results can vary as all animals are individuals with different diets, lifestyles and nutritional needs
If you choose to use injections: Vet your provider thoroughly, demand transparency about sourcing, and track your health outcomes